HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 08, August 2017 – Eye – the Window to your Soul       » Palm-Sized PCR Device for Rapid Real-Time Detection of Viruses       » Scientists Uncover New Mechanism for Diabetic Neuropathy       » China Enlists AI to Diagnose Breast Cancer       » Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore       » Guardian Partners with MyDoc to Address Singapore's Population Health Needs through Integrating Technology and Self-Care       » Database Boosts Shanghai's Technology Aim      
EYE on CHINA
SIIC to provide funding to biotech projects
The Supra Integration and Incubation Center (SIIC), an institute dedicated to promoting the domestic biotechnology industry, will start a funding program for the pharmaceutical sector this year.

The center will provide funds for both research institutes and business start-ups, according to the organization's managing director Soo Whai-jen.

The center plans to provide NT$50 million (US$1.67 million) to each start-up over a three-year period and at least NT$100 million a year for qualified research institutes, Soo said.

The funding program comes as biotech companies and researchers are finding it increasingly difficult to gain financial support, with only a few obtaining funds from venture capital firms.

“We aim to offer the necessary help to companies and research projects, which have business potential, but are unable to gain financial support from the private sector,” Minister Without Portfolio Simon Chang said.

The center aims to provide funds to qualified candidates with less red tape, the center said.

Soo said the center will simplify its review process from three stages to one stage and expedite the appropriation process to guarantee the money will be in place one week after approval.

Furthermore, the center will provide funding on a milestone basis, offering its recipients funds based on completion of every stage of a project's development, he said.

There are currently 10 drug development projects and four medical equipment development cases under review, according to the center.

“The nation's biotechnology resources focus too much on research and not enough on development,” says SIIC chief operating officer Wang Ling-mei.

“The center's goal is to increase the rate of research results transformed into final products by allocating more funding to product development and related research project,” Wang added.

Many experts in Taiwan are more willing to write an academic thesis, which requires only 10 experiments, and less willing to create a pharmaceutical product, which needs to pass 100 experiments, Wang said.

“Product development is a tedious, but necessary procedure because the devil is in the details,” she said.

The center also launched a training program, which focuses on acquiring knowledge of medical law, marketing and business planning for experts with academic achievements in biotechnology, with the hope that they will help bridge the gap between the academic field and the pharmaceutical sector.

“The assistance provided by the government can benefit local pharmaceutical firms, which desperately need funding,” Max Chan Chief Financial Officer of local drug maker TaiGen Biotechnology Co said in a telephone interview.

Click here for the complete issue.

NEWS CRUNCH  
news Vitafoods Asia 2017: Industry players optimistic of future
news Nestlé Introduces their Singapore R&D Centre
news Vitafoods Asia Elevates 2017 Learning Programme
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy